Vir Biotechnology, Inc.·4

Aug 3, 5:45 PM ET

Rice Steven J. 4

4 · Vir Biotechnology, Inc. · Filed Aug 3, 2020

Insider Transaction Report

Form 4
Period: 2020-07-30
Rice Steven J.
Chief Administrative Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-07-30+40,00040,000 total
    Exercise: $47.06Exp: 2030-07-30Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]1/4 of the shares subject to the stock option vest and become exercisable on July 30, 2021, and the remainder vest in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION